Get the Stockscreener App
60.22
0.15%
-0.09
After Hours:
60.22
State Street Spdr S P Pharmaceuticals Etf stock is traded at $60.22, with a volume of 33,920.
It is down -0.15% in the last 24 hours and up +5.97% over the past month.
See More
Previous Close:
$60.31
Open:
$60.45
24h Volume:
33,920
Relative Volume:
0.64
Market Cap:
$229.97M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+3.31%
1M Performance:
+5.97%
6M Performance:
+8.02%
1Y Performance:
+44.59%
1-Day Range:
$59.66
$60.45
1-Week Range:
$58.10
$60.86
52-Week Range:
$40.26
$60.86
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Company Profile
Name
State Street Spdr S P Pharmaceuticals Etf
Sector
Industry
Phone
-
Address
-
Compare XPH vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XPH
State Street Spdr S P Pharmaceuticals Etf
|
60.22 | 229.97M | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
370.37 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
750.33 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
752.01 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
296.58 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
729.86 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Latest News
Biotechnology vs. Pharmaceuticals: What Are the Differences? - The Motley Fool
State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio? - AOL.com
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Yahoo Finance
Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech - AOL.com
Healthcare ETFs: From Broad Exposure to Big Breakthroughs - ETF Trends
Fastest Growing ETFs of 2026 - ETF.com
Biotech is losing momentum despite strong M&A (XBI:NYSEARCA) - Seeking Alpha
Beyond SpaceX: ETFs That Can Help to Tap the Growing Space Economy - TradingView
Biotech ETFs: Which ETF Offers Lower Fees? IBBQ or XPH? - AOL.com
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a strong ETF right now? - MSN
ETFs Investing in Jazz Pharmaceuticals Public Limited Company Stocks - TradingView
Financial ETFs see $2.3B outflow as Fed uncertainty grows - MSN
XLV vs. PINK Healthcare ETF Comparison: Cost, Performance, and PortfolioNews and Statistics - IndexBox
PJP vs XBI: Pharmaceutical vs Biotech ETF Comparison for InvestorsNews and Statistics - IndexBox
Should State Street SPDR Portfolio S&P 500 ETF (SPYM) Be on Your Investing Radar? - sharewise.com
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - Yahoo Finance
Should you invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - MSN
Gilead, Merck, Eli Lilly Lead $106B Biopharma Takeover Wave In 2026 - TradingView
SPDR S&P Pharmaceuticals and First Trust NYSE Arca Biotech ETFs Offer Distinct Healthcare Paths - sekbernews.id
State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio? - The Motley Fool
Invesco vs. SPDR Healthcare ETFs: Biotech and Pharma Fund ComparisonNews and Statistics - IndexBox
Vanguard index product becomes first ETF to top $1 trillion in assets - Reuters
ETFs Investing in Indivior Pharmaceuticals, Inc. Stocks - TradingView
Where to Invest $10,000 Right Now - Bloomberg.com
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - Yahoo Finance
Market Movers | Winners: SILO, LASE, BJDX | Losers: FULC, HRTX, SPCE - Trefis
Energy Cycle Upside or Midstream Income? XOP vs. MLPX - The Motley Fool
SPDR S&P Oil & Gas E&P ETF vs. Global X MLP & Energy Infrastructure ETF ComparisonNews and Statistics - IndexBox
Why I Stopped Buying VOO And QQQAnd What I Am Buying Instead (SP500) - Seeking Alpha
Beyond the AI Boom: 3 Forgotten Sectors to Buy Amid Historic Market Disconnect - Barron's
State Street's Health Care ETF Tops Invesco's on Yield and Returns - The Motley Fool
GXC: Deflation And Unemployment Spiral Risks For China (NYSEARCA:GXC) - Seeking Alpha
S&P 500 Movers | Winners: MGM, CDW, DDOG | Losers: FDX, CBOE, QCOM - Trefis
Market Movers | Winners: AIM, ANY, SUUN | Losers: ABVE, NXTC, CRMT - Trefis
Healthcare ETF Face-off: VHT, IXJ and XBI – Which Fits Your Portfolio? - NAI500
ALLW: Protecting Your Portfolio From Macroeconomic Risk (NASDAQ:ALLW) - Seeking Alpha
Midday Need to Know: Oil spikes, Anthropic files for IPO & more (SPY:NYSEARCA) - Seeking Alpha
SOXX: The Party May Be Over (NASDAQ:SOXX) - Seeking Alpha
My Current View Of The S&P 500 Index: June 2026 Edition (Technical Analysis) (NYSEARCA:SPY) - Seeking Alpha
LH or MEDP: Which is the better value stock right now? - MSN
Market Movers | Winners: DEVS, REPL, OLOX | Losers: POAS, NCPL, SNBR - Trefis
Exchange-Traded Funds, Equity Futures Rise Pre-Bell Friday Amid US-Iran Deal Hopes - Moomoo
Is State Street SPDR S&P Semiconductor ETF (XSD) a Strong ETF Right Now? - Yahoo Finance
Large Cap Stocks Trading At 52-Week High - Trefis
May 26, 2026 Reflections: Time To Lighten Up Exposures? - Seeking Alpha
7 Best Socially Responsible Funds | InvestingU.S. News - U.S. News - Money
The Smartest Bank ETF to Own if the Fed Hikes Rates This Year - The Motley Fool
VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost - The Motley Fool
Is State Street SPDR S&P Biotech ETF (XBI) a strong ETF right now? - MSN
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Financials Data
There is no financial data for State Street Spdr S P Pharmaceuticals Etf (XPH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.10%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):